The ACADSB gene 2-Methylbutyrylglycinuria genetic test is a specialized diagnostic procedure aimed at identifying mutations in the ACADSB gene, which are linked to the rare metabolic disorder known as 2-Methylbutyrylglycinuria. This condition affects the body's ability to break down certain amino acids, leading to a buildup of specific substances that can be harmful. Symptoms of the disorder can vary and may include developmental delay, seizures, and metabolic crises, making early detection and management crucial for affected individuals.
The test involves analyzing the patient's DNA to detect mutations in the ACADSB gene, which provides instructions for making an enzyme necessary for the breakdown of the amino acid isoleucine. A mutation in this gene can disrupt this process, leading to the accumulation of toxic substances in the body.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test is priced at 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in the field of genetic diagnostics, ensuring accurate and reliable test results. This genetic test is crucial for families with a history of 2-Methylbutyrylglycinuria, as it can provide essential information for the management of the condition, including dietary restrictions and monitoring for potential complications.
The HSD3B2 gene plays a crucial role in the biosynthesis of all classes of hormonal steroids, including glucocorticoids, mineralocorticoids, and sex steroids. Mutations in the HSD3B2 gene can lead to 3-Beta-Hydroxysteroid Dehydrogenase Deficiency Type 2, a rare endocrine disorder that affects steroid hormone production. This condition can result in ambiguous genitalia in genetically male infants, adrenal insufficiency, and potentially life-threatening salt loss in early infancy.
To diagnose this condition, a genetic test targeting the HSD3B2 gene can be conducted. This test involves analyzing the DNA to identify mutations in the HSD3B2 gene that are known to cause the deficiency. It is a crucial step in confirming the diagnosis, which can then guide treatment and management strategies for affected individuals.
In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The cost of the test is 3200 AED. Conducting the test at DNA Labs UAE ensures that patients receive accurate and reliable results, thanks to the lab's commitment to using state-of-the-art genetic testing technologies and its team of experienced professionals. This test is not only pivotal for diagnosis but also for family planning and genetic counseling for families affected by 3-Beta-Hydroxysteroid Dehydrogenase Deficiency Type 2.
The HMGCL Gene 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the HMGCL gene. These mutations can lead to 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, a rare metabolic disorder that impedes the body's ability to break down certain proteins and fats, leading to a buildup of toxic substances and potential damage to organs. The test is crucial for early detection and management of the condition, which can significantly improve the quality of life for affected individuals. The test is priced at 4400 AED and involves a comprehensive analysis of the HMGCL gene to identify any genetic anomalies indicative of the deficiency. This genetic test is a valuable tool for individuals with a family history of the disorder or presenting symptoms, enabling timely intervention and personalized treatment plans.
The TTN Gene Tibial Muscular Dystrophy Tardive Genetic Test is a specialized diagnostic examination aimed at detecting mutations in the TTN gene, which are known to cause Tibial Muscular Dystrophy (TMD), a type of late-onset muscular dystrophy. This condition primarily affects the muscles at the front of the lower leg, leading to weakness and other related symptoms. The test is essential for individuals showing symptoms of TMD or those with a family history of the disease, as it helps in confirming the diagnosis and facilitating early intervention and management strategies.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test offers a comprehensive analysis of the TTN gene to identify any genetic alterations that might be responsible for the condition. The cost of the test is set at 4400 AED, reflecting the intricate technology and expertise required to accurately identify mutations in the gene.
By opting for this genetic test, patients and their families can gain valuable insights into the genetic underpinnings of Tibial Muscular Dystrophy, allowing for better-informed decisions regarding treatment and management of the condition. Moreover, the results from this test can also be crucial for genetic counseling, especially for individuals planning to start a family and wanting to understand the risk of passing the condition to their offspring.
The SLITRK1 Gene Tourette Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the SLITRK1 gene, which have been associated with the development of Tourette Syndrome. Tourette Syndrome is a neurological disorder characterized by repetitive, stereotyped, involuntary movements and vocalizations called tics. The presence of mutations in the SLITRK1 gene can suggest a genetic predisposition to this condition, providing crucial information for individuals and families seeking answers about Tourette Syndrome's underlying causes and risks.
This genetic test involves collecting a DNA sample, typically through a blood draw or a cheek swab, and analyzing the SLITRK1 gene for specific genetic changes. The process is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high accuracy and reliability of the results. The test is priced at 4400 AED, reflecting the sophisticated technology and expert analysis involved in identifying the genetic markers associated with Tourette Syndrome.
By opting for the SLITRK1 Gene Tourette Syndrome Genetic Test, individuals can gain valuable insights into their genetic makeup, enabling informed decisions about their health and well-being. It also provides a foundation for personalized treatment plans and interventions, potentially improving the quality of life for those affected by Tourette Syndrome.
The FUS Gene Tremor Essential Type 4 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the FUS gene, which are linked to Essential Tremor Type 4, a neurological condition characterized by involuntary, rhythmic shaking. Essential Tremor is a common movement disorder that primarily affects the hands but can also impact the head, voice, and other parts of the body. The FUS gene plays a crucial role in maintaining the normal function of nerve cells, and mutations in this gene can lead to the development of Essential Tremor, impacting an individual's daily life.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test provides a comprehensive analysis of the FUS gene to detect specific genetic alterations. Understanding these genetic mutations can be pivotal for individuals and families in managing the condition, guiding treatment decisions, and assessing the risk of passing the condition to future generations.
The cost of the FUS Gene Tremor Essential Type 4 Genetic Test is 4400 AED. Although the price may seem significant, the value of the insights gained from this test can be invaluable for affected individuals and their families, offering a clearer understanding of their condition and enabling more personalized healthcare strategies.
The DRD3 Gene Tremor Essential Type 1 Hereditary Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the DRD3 gene, which are associated with Essential Tremor Type 1. Essential Tremor is a neurological disorder that causes involuntary and rhythmic shaking, usually affecting the hands but can also impact other parts of the body. This hereditary condition often runs in families and can significantly impact a person's daily life.
The test is particularly valuable for individuals with a family history of Essential Tremor, as it can provide a definitive diagnosis, helping to distinguish this condition from other types of tremor or movement disorders. By analyzing a sample of the individual's DNA, the test can detect specific genetic variations in the DRD3 gene that are linked to the disorder, providing insights into the likelihood of developing the condition and the potential severity.
Administered at DNA Labs UAE, a leading provider of genetic testing services, the test ensures accuracy, confidentiality, and professional guidance throughout the process. The cost of the DRD3 Gene Tremor Essential Type 1 Hereditary Genetic Test is 4400 AED, an investment that offers individuals and families critical information for managing and planning for their healthcare needs. With this knowledge, affected individuals can explore appropriate treatment options and lifestyle adjustments to better manage their symptoms and improve their quality of life.
The TSC1 Gene Tuberous Sclerosis Genetic Test is a specific diagnostic tool designed to identify mutations in the TSC1 gene, which are linked to tuberous sclerosis complex (TSC). TSC is a genetic disorder that causes non-cancerous (benign) tumors to develop in vital organs of the body, including the brain, heart, kidneys, skin, and lungs. These mutations can be inherited from a parent or occur spontaneously.
The test is conducted at DNA Labs UAE, a facility renowned for its advanced genetic testing capabilities and adherence to international standards. The procedure involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the lab to detect any abnormalities in the TSC1 gene.
With a cost of 4400 AED, the TSC1 Gene Tuberous Sclerosis Genetic Test is an investment in understanding the genetic basis of TSC in affected individuals or families at risk. This information can be crucial for making informed decisions about treatment options, management strategies, and genetic counseling. Early detection through genetic testing can significantly improve the quality of life for those with TSC by enabling tailored medical interventions and monitoring for potential complications associated with the condition.
The TSC2 Gene Tuberous Sclerosis Type 2 Genetic Test is a specialized diagnostic tool aimed at identifying mutations in the TSC2 gene, which are linked to Tuberous Sclerosis Complex (TSC), a genetic disorder characterized by the growth of noncancerous (benign) tumors in many parts of the body. These mutations can lead to a range of symptoms, including skin abnormalities, seizures, developmental delays, and problems with the heart, kidneys, eyes, and lungs. The test is crucial for early detection, allowing for timely intervention and management of the condition.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis of the TSC2 gene to identify specific genetic alterations. This test is particularly important for families with a history of Tuberous Sclerosis Complex or individuals showing symptoms of the disorder. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the TSC2 gene. By opting for this test at DNA Labs UAE, patients and their families can gain valuable insights into their genetic makeup, enabling informed decisions about their health and management of Tuberous Sclerosis Complex.
The COL6A1 gene Ullrich Congenital Muscular Dystrophy genetic test is a specialized diagnostic tool designed to identify mutations in the COL6A1 gene, which are associated with Ullrich Congenital Muscular Dystrophy (UCMD). UCMD is a severe form of muscular dystrophy characterized by muscle weakness, joint stiffness, and in some cases, skin abnormalities. This condition is inherited in an autosomal recessive manner, meaning that two copies of the mutated gene, one from each parent, are required for a child to be affected.
The test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the test is 4400 AED, which covers the process of collecting a DNA sample, usually through a blood draw or cheek swab, and the subsequent laboratory analysis to detect the presence of mutations in the COL6A1 gene. Results from this test can provide crucial information for families affected by UCMD, including confirming a diagnosis, understanding the risk of passing the condition to future generations, and guiding treatment and management decisions. DNA Labs UAE employs state-of-the-art technology and adheres to stringent quality standards to ensure accurate and reliable test results.
